Literature DB >> 26044102

Impaired pulmonary vascular development in bronchopulmonary dysplasia.

Christopher D Baker1, Steven H Abman.   

Abstract

Bronchopulmonary dysplasia (BPD), the chronic lung disease associated with preterm birth, results from the disruption of normal pulmonary vascular and alveolar growth. Though BPD was once described as primarily due to postnatal injury from mechanical ventilation and oxygen therapy after preterm birth, it is increasingly appreciated that BPD results from antenatal and perinatal factors that interrupt lung development in infants born at the extremes of prematurity. The lung in BPD consists of a simplified parenchymal architecture that limits gas exchange and leads to increased cardiopulmonary morbidity and mortality. This review outlines recent advances in the understanding of pulmonary vascular development and describes how the disruption of these mechanisms results in BPD. We point to future therapies that may augment postnatal vascular growth to prevent and treat this severe chronic lung disease.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26044102      PMCID: PMC4469359          DOI: 10.1159/000381129

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  119 in total

1.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Inhaled nitric oxide reverses hypoxia induced lung hypoplasia in endothelial nitric oxide synthase-deficient mice.

Authors:  Vivek Balasubramaniam; Anne Maxey; Steven Abman
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

Review 3.  MicroRNA expression profiling studies on bronchopulmonary dysplasia: a systematic review and meta-analysis.

Authors:  Y Yang; J Qiu; Q Kan; X-G Zhou; X-Y Zhou
Journal:  Genet Mol Res       Date:  2013-10-30

Review 4.  The molecular basis for abnormal human lung development.

Authors:  Frederick Groenman; Sharon Unger; Martin Post
Journal:  Biol Neonate       Date:  2004-12-09

5.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

6.  Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.

Authors:  Bernard Thébaud; Faruqa Ladha; Evangelos D Michelakis; Monika Sawicka; Gavin Thurston; Farah Eaton; Kyoko Hashimoto; Gwyneth Harry; Alois Haromy; Greg Korbutt; Stephen L Archer
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

7.  Altered small airways in aged mice following neonatal exposure to hyperoxic gas.

Authors:  Megan O'Reilly; Richard Harding; Foula Sozo
Journal:  Neonatology       Date:  2013-11-19       Impact factor: 4.035

Review 8.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

9.  Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia.

Authors:  Christopher D Baker; Sharon L Ryan; David A Ingram; Gregory J Seedorf; Steven H Abman; Vivek Balasubramaniam
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

10.  Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization.

Authors:  Bi-Sen Ding; Daniel J Nolan; Peipei Guo; Alexander O Babazadeh; Zhongwei Cao; Zev Rosenwaks; Ronald G Crystal; Michael Simons; Thomas N Sato; Stefan Worgall; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

View more
  35 in total

1.  β-Naphthoflavone treatment attenuates neonatal hyperoxic lung injury in wild type and Cyp1a2-knockout mice.

Authors:  Krithika Lingappan; Paramahamsa Maturu; Yanhong Wei Liang; Weiwu Jiang; Lihua Wang; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-26       Impact factor: 4.219

2.  Acute Kidney Injury and Bronchopulmonary Dysplasia in Premature Neonates Born Less than 32 Weeks' Gestation.

Authors:  Michelle C Starr; Louis Boohaker; Laurie C Eldredge; Shina Menon; Russell Griffin; Dennis E Mayock; Linzi Li; David Askenazi; Sangeeta Hingorani
Journal:  Am J Perinatol       Date:  2019-11-27       Impact factor: 1.862

3.  Perinatal maternal antibiotic exposure augments lung injury in offspring in experimental bronchopulmonary dysplasia.

Authors:  Kent A Willis; David T Siefker; Michael M Aziz; Catrina T White; Naiha Mussarat; Charles K Gomes; Amandeep Bajwa; Joseph F Pierre; Stephania A Cormier; Ajay J Talati
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-23       Impact factor: 5.464

4.  Sexual dimorphism of the pulmonary transcriptome in neonatal hyperoxic lung injury: identification of angiogenesis as a key pathway.

Authors:  Cristian Coarfa; Yuhao Zhang; Suman Maity; Dimuthu N Perera; Weiwu Jiang; Lihua Wang; Xanthi Couroucli; Bhagavatula Moorthy; Krithika Lingappan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-17       Impact factor: 5.464

5.  Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice.

Authors:  Katelyn Dunigan-Russell; Vivian Lin; Mary Silverberg; Stephanie B Wall; Rui Li; John Gotham; Teodora Nicola; Anusha Sridharan; John Snowball; Cassidy Delaney; Qian Li; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-15       Impact factor: 5.464

Review 6.  Can maternal DHA supplementation offer long-term protection against neonatal hyperoxic lung injury?

Authors:  Krithika Lingappan; Bhagavatula Moorthy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

Review 7.  Should we still use vitamin A to prevent bronchopulmonary dysplasia?

Authors:  X I Couroucli; J L Placencia; L A Cates; G K Suresh
Journal:  J Perinatol       Date:  2016-05-26       Impact factor: 2.521

8.  A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Jennifer K Trittmann; Julie M Gastier-Foster; Erik J Zmuda; Jessica Frick; Lynette K Rogers; Veronica J Vieland; Louis G Chicoine; Leif D Nelin
Journal:  Acta Paediatr       Date:  2016-01-11       Impact factor: 2.299

9.  Postnatal Alveologenesis Depends on FOXF1 Signaling in c-KIT+ Endothelial Progenitor Cells.

Authors:  Xiaomeng Ren; Vladimir Ustiyan; Minzhe Guo; Guolun Wang; Craig Bolte; Yufang Zhang; Yan Xu; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

Review 10.  Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.

Authors:  Olena A Kolesnichenko; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.